Matt Hopkins
By this expert
The $5.3 Trillion Question Behind America’s COVID-19 Failure
That’s the amount of buybacks U.S. corporations funneled to shareholders during the past decade—rather than invest in technologies for the common good. This article is being published jointly by INET and The American Prospect
How “Maximizing Shareholder Value” Minimized the Strategic National Stockpile: The $5.3 Trillion Question for Pandemic Preparedness Raised by the Ventilator Fiasco
The success of projects for pandemic preparedness and response depends on the strength of government-business collaborations.
4 Ways to Eradicate the Corporate Disease That is Worsening the Covid-19 Pandemic
It’s time for business executives, employees, and taxpayers to come together to help get us out of the pandemic and create conditions for a sustainable and equitable future
Financialization of the U.S. Pharmaceutical Industry
Pharmaceutical drugs are often a matter of life or death. It should be a prime objective of government policy to rid the industry of financialization.
Featuring this expert
INET working paper on how maximizing shareholder value led to minimizing national interests is cited in The American Prospect
“If companies continue to prioritize maximizing shareholder wealth at the expense of other key stakeholders, and at the expense of investing in innovation, then the Green New Deal could reinforce long-standing income and wealth inequities and the decline in innovation in the U.S. economy (for an important example, Bill Lazonick and Matt Hopkins document how maximizing shareholder value minimized the strategic national stockpile for ventilators and personal protective equipment).” —Lenore M Palladino